Azmat, A. et al. 2019. RESPONSE RATES TO SOFOSBUVIR AND DACLATASVIR IN CHRONIC HEPATITIS C PATIENTS. Journal of Medical Sciences. 27, 2 (Jun. 2019), 85–89.